Abstract
Original language | English |
---|---|
Pages (from-to) | 156-161 |
Number of pages | 6 |
Journal | J. Trace Elem. Med. Biol. |
Volume | 56 |
DOIs | |
Publication status | Published - 2019 |
Keywords
- Copper
- Free copper
- Metals
- Selenium manganese
- Type 1 diabetes
- Zinc
- beryllium
- carrier protein
- ceruloplasmin
- copper
- manganese
- molybdenum
- nonceruloplasmin bound copper
- selenium
- unclassified drug
- zinc
- adult
- Article
- ceruloplasmin blood level
- cohort analysis
- controlled study
- copper blood level
- female
- human
- inductively coupled plasma mass spectrometry
- insulin dependent diabetes mellitus
- major clinical study
- male
- manganese blood level
- predictive value
- priority journal
- selenium blood level
- zinc blood level
Fingerprint
Dive into the research topics of 'Serum copper profile in patients with type 1 diabetes in comparison to other metals: Journal of Trace Elements in Medicine and Biology'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Serum copper profile in patients with type 1 diabetes in comparison to other metals : Journal of Trace Elements in Medicine and Biology. / Squitti, R.; Negrouk, V.; Perera, M.; Llabre, M.M.; Ricordi, C.; Rongioletti, M.C.A.; Mendez, A.J.
In: J. Trace Elem. Med. Biol., Vol. 56, 2019, p. 156-161.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Serum copper profile in patients with type 1 diabetes in comparison to other metals
T2 - Journal of Trace Elements in Medicine and Biology
AU - Squitti, R.
AU - Negrouk, V.
AU - Perera, M.
AU - Llabre, M.M.
AU - Ricordi, C.
AU - Rongioletti, M.C.A.
AU - Mendez, A.J.
N1 - Cited By :1 Export Date: 10 February 2020 CODEN: JTEBF Correspondence Address: Squitti, R.; Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio FatebenefratelliItaly; email: rosanna.squitti@afar.it Chemicals/CAS: beryllium, 7440-41-7; carrier protein, 80700-39-6; ceruloplasmin, 9031-37-2; copper, 15158-11-9, 7440-50-8; manganese, 16397-91-4, 7439-96-5; molybdenum, 7439-98-7; selenium, 7782-49-2; zinc, 7440-66-6, 14378-32-6 Funding details: Diabetes Research Institute Foundation, DRIF Funding text 1: Funding for this study was provided by the Diabetes Research Institute Foundation . References: Skyler, J.S., Bakris, G.L., Bonifacio, E., Darsow, T., Eckel, R.H., Groop, L., Groop, P.H., Ratner, R.E., Differentiation of diabetes by pathophysiology, natural history, and prognosis (2017) Diabetes, 66 (2), pp. 241-255; Newman, J.D., Rockman, C.B., Kosiborod, M., Guo, Y., Zhong, H., Weintraub, H.S., Schwartzbard, A.Z., Berger, J.S., Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease (2017) Am. Heart J., 184, pp. 114-120; de Ferranti, S.D., de Boer, I.H., Fonseca, V., Fox, C.S., Golden, S.H., Lavie, C.J., Magge, S.N., Eckel, R.H., Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association (2014) Diabetes Care, 37 (10), pp. 2843-2863; Wong, T.Y., Sun, J., Kawasaki, R., Ruamviboonsuk, P., Gupta, N., Lansingh, V.C., Maia, M., Taylor, H.R., Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings (2018) Ophthalmology, 125 (10), pp. 1608-1622; Verrotti, A., Prezioso, G., Scattoni, R., Chiarelli, F., Autonomic neuropathy in diabetes mellitus (2014) Front. Endocrinol., 5, p. 205; Barrell, K., Smith, A.G., Peripheral neuropathy (2019) Med. Clin. North Am., 103 (2), pp. 383-397; Krolewski, A.S., Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes (2015) Diabetes Care, 38 (6), pp. 954-962; W.H. Organization, Global Report on Diabetes (2016), http://www.who.int/diabetes/global-report/en/; Kim, H.N., Song, S.W., Concentrations of chromium, selenium, and copper in the hair of viscerally obese adults are associated with insulin resistance (2014) Biol. Trace Elem. Res., 158 (2), pp. 152-157; Wolff, S.P., Dean, R.T., Glucose autoxidation and protein modification. The potential role of ‘autoxidative glycosylation’ in diabetes (1987) Biochem. J., 245 (1), pp. 243-250; Thorpe, S.R., Baynes, J.W., Role of the Maillard reaction in diabetes mellitus and diseases of aging (1996) Drugs Aging, 9 (2), pp. 69-77; Price, D.L., Rhett, P.M., Thorpe, S.R., Baynes, J.W., Chelating activity of advanced glycation end-product inhibitors (2001) J. Biol. Chem., 276 (52), pp. 48967-48972; Cooper, G.J., Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease (2011) Drugs, 71 (10), pp. 1281-1320; Linder, M.C., Ceruloplasmin and other copper binding components of blood plasma and their functions: an update (2016) Metallomics, 8 (9), pp. 887-905; Gaggelli, E., Kozlowski, H., Valensin, D., Valensin, G., Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis) (2006) Chem. Rev., 106 (6), pp. 1995-2044; La Fontaine, S., Mercer, J.F., Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis (2007) Arch. Biochem. Biophys., 463 (2), pp. 149-167; Hellman, N.E., Kono, S., Mancini, G.M., Hoogeboom, A.J., De Jong, G.J., Gitlin, J.D., Mechanisms of copper incorporation into human ceruloplasmin (2002) J. Biol. Chem., 277 (48), pp. 46632-46638; Roberts, E.A., Sarkar, B., Liver as a key organ in the supply, storage, and excretion of copper (2008) Am. J. Clin. Nutr., 88 (3), pp. 851S-854S; Walshe, J.M., B. Clinical Investigations Standing Committee of the Association of Clinical, Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically (2003) Ann. Clin. Biochem., 40, pp. 115-121; Qiu, Q., Zhang, F., Zhu, W., Wu, J., Liang, M., Copper in diabetes mellitus: a meta-analysis and systematic review of plasma and serum studies (2017) Biol. Trace Elem. Res., 177 (1), pp. 53-63. , Epub 2016 Oct 26; Li, D.-D., Zhang, W., Wang, Z.-Y., Zhao, P., Serum copper, zinc, and iron levels in patients with Alzheimer's disease: a meta-analysis of case-control studies (2017) Front. Aging Neurosci., 9 (300); Mariani, S., Ventriglia, M., Simonelli, I., Donno, S., Bucossi, S., Vernieri, F., Melgari, J.M., Squitti, R., Fe and Cu do not differ in Parkinson's disease: a replication study plus meta-analysis (2013) Neurobiol. Aging, 34 (2), pp. 632-633; Squitti, R., Fostinelli, S., Siotto, M., Ferrari, C., Binetti, G., Benussi, L., Rongioletti, M., Ghidoni, R., Serum copper is not altered in frontotemporal lobar degeneration (2018) J. Alzheimers Dis., 63 (4), pp. 1427-1432; Calderon, R.M., Diaz, S., Szeto, A., Llinas, J.A., Hughes, T.A., Mendez, A.J., Goldberg, R.B., Elevated lipoprotein lipase activity does not account for the association between adiponectin and HDL in type 1 diabetes (2015) J. Clin. Endocrinol. Metab., 100 (7), pp. 2581-2588; El Balkhi, S., Poupon, J., Trocello, J.M., Leyendecker, A., Massicot, F., Galliot-Guilley, M., Woimant, F., Determination of ultrafiltrable and exchangeable copper in plasma: stability and reference values in healthy subjects (2009) Anal. Bioanal. Chem., 394 (5), pp. 1477-1484; McMillin, G.A., Travis, J.J., Hunt, J.W., Direct measurement of free copper in serum or plasma ultrafiltrate (2009) Am. J. Clin. Pathol., 131 (2), pp. 160-165; Lowe, J., Taveira-da-Silva, R., Hilario-Souza, E., Dissecting copper homeostasis in diabetes mellitus (2017) IUBMB Life, 69 (4), pp. 255-262; Lau, A.L., Failla, M.L., Urinary excretion of zinc, copper and iron in the streptozotocin-diabetic rat (1984) J. Nutr., 114 (1), pp. 224-233; Squitti, R., Mendez, A.J., Simonelli, I., Ricordi, C., Diabetes and Alzheimer's disease: can elevated free copper predict the risk of the disease? (2017) J. Alzheimers Dis., 56 (3), pp. 1055-1064; Hilario-Souza, E., Cuillel, M., Mintz, E., Charbonnier, P., Vieyra, A., Cassio, D., Lowe, J., Modulation of hepatic copper-ATPase activity by insulin and glucagon involves protein kinase A (PKA) signaling pathway (2016) Biochim. Biophys. Acta, 1862 (11), pp. 2086-2097; Squitti, R., Ventriglia, M., Gennarelli, M., Colabufo, N.A., El Idrissi, I.G., Bucossi, S., Mariani, S., Bonvicini, C., Non-ceruloplasmin copper distincts subtypes in Alzheimer's disease: a genetic study of ATP7B frequency (2017) Mol. Neurobiol., 54 (1), pp. 671-681; McCann, C.J., Jayakanthan, S., Siotto, M., Yang, N., Osipova, M., Squitti, R., Lutsenko, S., Single nucleotide polymorphisms in the human ATP7B gene modify the properties of the ATP7B protein (2019) Metallomics, 11 (6), pp. 1128-1139; Squitti, R., Polimanti, R., Siotto, M., Bucossi, S., Ventriglia, M., Mariani, S., Vernieri, F., Rossini, P.M., ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease (2013) Neuromol. Med., 15 (3), pp. 515-522; Squitti, R., Ghidoni, R., Simonelli, I., Ivanova, I.D., Colabufo, N.A., Zuin, M., Benussi, L., Siotto, M., Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators (2018) J. Trace Elem. Med. Biol., 45, pp. 181-188; Alghobashy, A.A., Alkholy, U.M., Talat, M.A., Abdalmonem, N., Zaki, A., Ahmed, I.A., Mohamed, R.H., Trace elements and oxidative stress in children with type 1 diabetes mellitus (2018) Diabetes Metab. Syndr. Obes.: Targets Ther., 11, pp. 85-92; Peruzzu, A., Solinas, G., Asara, Y., Forte, G., Bocca, B., Tolu, F., Malaguarnera, L., Madeddu, R., Association of trace elements with lipid profiles and glycaemic control in patients with type 1 diabetes mellitus in northern Sardinia, Italy: an observational study (2015) Chemosphere, 132, pp. 101-107; Forte, G., Bocca, B., Peruzzu, A., Tolu, F., Asara, Y., Farace, C., Oggiano, R., Madeddu, R., Blood metals concentration in type 1 and type 2 diabetics (2013) Biol. Trace Elem. Res., 156 (1-3), pp. 79-90; Vinceti, M., Filippini, T., Rothman, K.J., Selenium exposure and the risk of type 2 diabetes: a systematic review and meta-analysis (2018) Eur. J. Epidemiol., 33 (9), pp. 789-810; Oo, S.M., Misu, H., Saito, Y., Tanaka, M., Kato, S., Kita, Y., Takayama, H., Takamura, T., Serum selenoprotein P, but not selenium, predicts future hyperglycemia in a general Japanese population (2018) Sci. Rep., 8 (1), p. 16727; McClung, J.P., Roneker, C.A., Mu, W., Lisk, D.J., Langlais, P., Liu, F., Lei, X.G., Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase (2004) Proc. Natl. Acad. Sci. U. S. A., 101 (24), pp. 8852-8857; Mita, Y., Nakayama, K., Inari, S., Nishito, Y., Yoshioka, Y., Sakai, N., Sotani, K., Saito, Y., Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models (2017) Nat. Commun., 8 (1), p. 1658; Uriu-Adams, J.Y., Rucker, R.B., Commisso, J.F., Keen, C.L., Diabetes and dietary copper alter 67Cu metabolism and oxidant defense in the rat (2005) J. Nutr. Biochem., 16 (5), pp. 312-320; Ozcelik, D., Tuncdemir, M., Ozturk, M., Uzun, H., Evaluation of trace elements and oxidative stress levels in the liver and kidney of streptozotocin-induced experimental diabetic rat model (2011) Gen. Physiol. Biophys., 30 (4), pp. 356-363; Takata, I., Kawamura, N., Myint, T., Miyazawa, N., Suzuki, K., Maruyama, N., Mino, M., Taniguchi, N., Glycated Cu, Zn-superoxide dismutase in rat lenses: evidence for the presence of fragmentation in vivo (1996) Biochem. Biophys. Res. Commun., 219 (1), pp. 243-248; Nazem, M.R., Asadi, M., Jabbari, N., Allameh, A., Effects of zinc supplementation on superoxide dismutase activity and gene expression, and metabolic parameters in overweight type 2 diabetes patients: a randomized, double-blind, controlled trial (2019) Clin. Biochem., 69, pp. 15-20
PY - 2019
Y1 - 2019
N2 - Background: Type 1 diabetes (T1D) is a chronic condition in which the pancreas loses the ability to produce insulin due to an autoimmune destruction of the insulin producing beta cells in the pancreatic islets of Langerhans. Pathophysiological complications related to diabetes include micro and macrovascular disease, nephropathy, and neuropathy that can also be affected by environmental factors such as lifestyle and diet. Objectives: The current study aimed to evaluate the serum levels of total copper, the copper-carrying protein, ceruloplasmin and nonceruloplasmin bound copper (nonceruloplasmin-Cu) and other essential and environmental metals and metalloids in subjects with T1D compared with healthy controls. Methods: A cohort of 63 subjects with T1D attending Diabetes Clinics at the University of Miami and 65 healthy control subjects was studied. Metals and metalloids were measured by inductively coupled plasma mass spectrometry. Results: A main finding of this study was that total copper and ceruloplasmin levels were higher in persons with T1D compared to healthy controls. In comparison to other metals and clinical variables, elevated copper was the strongest factor associated with T1D resulting in a15-fold increased odds of having the disease per standard deviation increase. Conclusion: Our results suggest a metal and metalloid perturbation in T1D with a significant involvement of Copper dysfunction in the disease pathology, possibly linked to inflammatory processes. © 2019 Elsevier GmbH
AB - Background: Type 1 diabetes (T1D) is a chronic condition in which the pancreas loses the ability to produce insulin due to an autoimmune destruction of the insulin producing beta cells in the pancreatic islets of Langerhans. Pathophysiological complications related to diabetes include micro and macrovascular disease, nephropathy, and neuropathy that can also be affected by environmental factors such as lifestyle and diet. Objectives: The current study aimed to evaluate the serum levels of total copper, the copper-carrying protein, ceruloplasmin and nonceruloplasmin bound copper (nonceruloplasmin-Cu) and other essential and environmental metals and metalloids in subjects with T1D compared with healthy controls. Methods: A cohort of 63 subjects with T1D attending Diabetes Clinics at the University of Miami and 65 healthy control subjects was studied. Metals and metalloids were measured by inductively coupled plasma mass spectrometry. Results: A main finding of this study was that total copper and ceruloplasmin levels were higher in persons with T1D compared to healthy controls. In comparison to other metals and clinical variables, elevated copper was the strongest factor associated with T1D resulting in a15-fold increased odds of having the disease per standard deviation increase. Conclusion: Our results suggest a metal and metalloid perturbation in T1D with a significant involvement of Copper dysfunction in the disease pathology, possibly linked to inflammatory processes. © 2019 Elsevier GmbH
KW - Copper
KW - Free copper
KW - Metals
KW - Selenium manganese
KW - Type 1 diabetes
KW - Zinc
KW - beryllium
KW - carrier protein
KW - ceruloplasmin
KW - copper
KW - manganese
KW - molybdenum
KW - nonceruloplasmin bound copper
KW - selenium
KW - unclassified drug
KW - zinc
KW - adult
KW - Article
KW - ceruloplasmin blood level
KW - cohort analysis
KW - controlled study
KW - copper blood level
KW - female
KW - human
KW - inductively coupled plasma mass spectrometry
KW - insulin dependent diabetes mellitus
KW - major clinical study
KW - male
KW - manganese blood level
KW - predictive value
KW - priority journal
KW - selenium blood level
KW - zinc blood level
U2 - 10.1016/j.jtemb.2019.08.011
DO - 10.1016/j.jtemb.2019.08.011
M3 - Article
VL - 56
SP - 156
EP - 161
JO - J. Trace Elem. Med. Biol.
JF - J. Trace Elem. Med. Biol.
SN - 0946-672X
ER -